Clinical Utility of Lefamulin: If Not Now, When?

PURPOSE OF REVIEW: The looming threat of antimicrobial resistance requires robust stewardship and new developments in infectious diseases pharmacotherapy. This review discusses the pertinent spectrum and clinical data of lefamulin (Xenleta®), with a focus on potential real-world use. RECENT FINDINGS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercuro, Nicholas J., Veve, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Antimicrobial Development and Drug Resistance (KC Claeys and J Smith, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344045/
https://www.ncbi.nlm.nih.gov/pubmed/32834786
http://dx.doi.org/10.1007/s11908-020-00732-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344045/
https://www.ncbi.nlm.nih.gov/pubmed/32834786
http://dx.doi.org/10.1007/s11908-020-00732-z

Ejemplares similares